WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 11 |
2.28 |
ml/min/100g |
0.07 |
0.23 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
168 |
days |
99990 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) and bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 16 |
3.19 |
ml/min/100g |
0.13 |
0.52 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
168 |
days |
99994 |
2378 |
MWF/ZtmRrrc |
renal plasma flow to body weight ratio |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney plasma flow trait |
male |
126 days
| 7 |
2.44 |
ml/min/100g |
0.28 |
0.73 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
|
0 |
|
100939 |
2541 |
MWF/ZtmRrrc |
renal plasma flow to body weight ratio |
enalapril (50 mg/l) (for 182 days) |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney plasma flow trait |
male |
246 days
| 6 |
1.71 |
ml/min/100g |
0.09 |
0.23 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
|
0 |
|
100942 |
2541 |
MWF/ZtmRrrc |
renal plasma flow to body weight ratio |
control condition |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney plasma flow trait |
male |
246 days
| 8 |
1.72 |
ml/min/100g |
0.07 |
0.19 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
|
0 |
|
100941 |
2541 |
SD |
renal plasma flow to body weight ratio |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
kidney plasma flow trait |
male |
420 days-450 days |
9 |
1.0 |
ml/min/100g |
0.06 |
0.18 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
|
0 |
|
101231 |
2582 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
2.33 |
ml/min/100g |
0.09 |
0.25 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
28 |
days |
99952 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) and bosentan (100 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 6 |
2.42 |
ml/min/100g |
0.09 |
0.22 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
28 |
days |
99954 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then bosentan (100 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 17 |
3.3 |
ml/min/100g |
0.11 |
0.45 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
168 |
days |
99992 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
3.09 |
ml/min/100g |
0.18 |
0.51 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
28 |
days |
99951 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 14 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 8 |
2.32 |
ml/min/100g |
0.11 |
0.31 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
28 |
days |
99953 |
2378 |
SD |
renal plasma flow to body weight ratio |
control condition |
Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. |
kidney plasma flow trait |
male |
90 days
| 9 |
0.97 |
ml/min/100g |
0.05 |
0.15 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
|
0 |
|
101230 |
2582 |
MWF/ZtmRrrc |
renal plasma flow to body weight ratio |
enalapril (50 mg/l) (for 60 days) |
Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. |
kidney plasma flow trait |
male |
126 days
| 8 |
2.84 |
ml/min/100g |
0.14 |
0.39 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
|
0 |
|
100940 |
2541 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 17 |
1.72 |
ml/min/100g |
0.11 |
0.45 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
168 |
days |
99991 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then streptozotocin (35 mg/kg) then enalapril (10 mg/kg/d) (for 154 days) |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 16 |
3.15 |
ml/min/100g |
0.13 |
0.52 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
168 |
days |
99993 |
2378 |
WKY |
renal plasma flow to body weight ratio |
unilateral nephrectomy (for 28 days) then vehicle control condition |
Ding SS, et al., J Cardiovasc Pharmacol. 2003 Jul;42(1):48-54. |
kidney plasma flow trait |
male |
0 days
| 7 |
2.16 |
ml/min/100g |
0.18 |
0.48 |
p-aminohippurate analysis by liquid phase colorimetry |
0.0 |
unx |
28 |
days |
99950 |
2378 |